Latest news
The Bull Case For Incyte (INCY) Could Change Following New EU Opzelura Atopic Dermatitis Approval - webull.comwebull.com · Mon, 03 Aug 2026 01:38:09 GMTIncyte (INCY) Wins EU Approval For Opzelura In Adult Moderate Atopic Dermatitis - Yahoo FinanceYahoo Finance · Sat, 01 Aug 2026 07:00:00 GMTIncyte (INCY) Wins European Approval For Opzelura In Adult Atopic Dermatitis - simplywall.stsimplywall.st · Thu, 30 Jul 2026 07:00:00 GMTOpzelura® (ruxolitinib) Cream Becomes First Steroid-Free Topical JAK Inhibitor Approved in the European Union for Adults with Moderate Atopic Dermatitis - Yahoo FinanceYahoo Finance · Wed, 29 Jul 2026 07:00:00 GMT